Increased production of prostaglandin D2 in patients with systemic mastocytosis.
D000328:Adult; D000818:Animals; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008407:Mast Cells / Q000378:metabolism; D008875:Middle Aged; D011323:Primates; D011453:Prostaglandins / Q000096:biosynthesis*; D011457:Prostaglandins D / Q000096:biosynthesis* / Q000652:urine; D014582:Urticaria Pigmentosa / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology
D006634:Histamine H1 Antagonists; D006635:Histamine H2 Antagonists; D011453:Prostaglandins; D011457:Prostaglandins D; D001241:Aspirin